Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 5174929, 6 pages
http://dx.doi.org/10.1155/2016/5174929
Research Article

Evaluation of Adipokines, Inflammatory Markers, and Sex Hormones in Simple and Complex Breast Cysts’ Fluid

1Department of Endocrinological Gynecology, Medical Faculty in Katowice, Medical University of Silesia, 40-752 Katowice, Poland
2Department of Statistics in Sosnowiec, Medical University of Silesia, 40-752 Katowice, Poland
3Pathophysiology Unit, Department of Pathophysiology, Medical Faculty in Katowice, Medical University of Silesia, 20-093 Katowice, Poland
4Health Promotion and Obesity Management Unit, Department of Pathophysiology, Medical Faculty in Katowice, Medical University of Silesia, 40-752 Katowice, Poland

Received 8 January 2016; Revised 2 April 2016; Accepted 13 April 2016

Academic Editor: Michele Malaguarnera

Copyright © 2016 Paweł Madej et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Y. Wang and I. S. Fentiman, “Epidemiology and endocrinology of benign breast disease,” Breast Cancer Research and Treatment, vol. 6, no. 1, pp. 5–36, 1985. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Dixon, A. B. Lumsden, and W. R. Miller, “The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease,” European Journal of Cancer and Clinical Oncology, vol. 21, no. 9, pp. 1047–1050, 1985. View at Publisher · View at Google Scholar · View at Scopus
  3. E. A. Sickles, R. A. Filly, and P. W. Callen, “Benign breast lesions: ultrasound detection and diagnosis,” Radiology, vol. 151, no. 2, pp. 467–470, 1984. View at Publisher · View at Google Scholar
  4. L. A. Venta, J. P. Kim, C. E. Pelloski, and M. Morrow, “Management of complex breast cysts,” American Journal of Roentgenology, vol. 173, no. 5, pp. 1331–1336, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Houssami, L. Irwing, and O. Ung, “Review of complex breast cysts: implications for cancer detection and clinical practice,” ANZ Journal of Surgery, vol. 75, no. 12, pp. 1080–1085, 2005. View at Publisher · View at Google Scholar
  6. I. Nyirjesy and F. S. Billingsley, “Benign breast disease,” Current Opinion in Obstetrics and Gynecology, vol. 5, no. 6, pp. 744–749, 1993. View at Google Scholar · View at Scopus
  7. T. G. Hislop and J. M. Elwood, “Risk factors for benign breast disease: a 30-year cohort study,” Canadian Medical Association Journal, vol. 124, no. 3, pp. 283–291, 1981. View at Google Scholar · View at Scopus
  8. H. Hille, M. Vetter, and B. J. Hackelöer, “The accuracy of BI-RADS classification of breast ultrasound as a first-line imaging method,” Ultraschall in der Medizin, vol. 33, no. 2, pp. 160–163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. S. H. Tsung, T. Y. Wang, S. M. Wang, and P.-S. Yang, “Cytological and biochemical studies of breast cyst fluid,” Breast, vol. 14, no. 1, pp. 37–41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Stanosz, B. Blicharczyk-Zalewska, G. Wilk, and M. Kubisa, “Relationship between estrogen, progesterone, total testosterone, androstenedione, and epidural growth factor in blood and breast cyst fluid,” Ginekologia Polska, vol. 73, no. 6, pp. 523–528, 2002. View at Google Scholar · View at Scopus
  11. V. Dubois, T. Jardé, L. Delort et al., “Leptin induces a proliferative response in breast cancer cells but not in normal breast cells,” Nutrition and Cancer, vol. 66, no. 4, pp. 645–655, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Babaei, D. Moslemi, H. Parsian, S. Khafri, M. Pouramir, and A. Mosapour, “Relationship of obesity with serum concentrations of leptin, CRP and IL-6 in breast cancer survivors,” Journal of the Egyptian National Cancer Institute, vol. 27, no. 4, pp. 223–229, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. A. M. A. Assiri and H. F. M. Kamel, “Evaluation of diagnostic and predictive value of serum adipokines: leptin, resistin and visfatin in postmenopausal breast cancer,” Obesity Research & Clinical Practice, 2015. View at Publisher · View at Google Scholar
  14. A. M. A. Assiri, H. F. M. Kamel, and M. F. R. Hassanien, “Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers,” Disease Markers, vol. 2015, Article ID 253519, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S.-A. Lee, H. Sung, W. Han, D.-Y. Noh, S.-H. Ahn, and D. Kang, “Serum adiponectin but not leptin at diagnosis as a predictor of breast cancer survival,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 15, pp. 6137–6143, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Budai, I. Számel, Z. Sulyok et al., “Characteristics of cystic breast disease with special regard to breast cancer development,” Anticancer Research, vol. 21, no. 1 B, pp. 749–752, 2001. View at Google Scholar · View at Scopus
  17. R. Karim, F. Z. Stanczyk, R. D. Brinton, J. Rettberg, H. N. Hodis, and W. J. Mack, “Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women,” Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 2, pp. 508–515, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. A. L. Strong, J. F. Ohlstein, B. A. Biagas et al., “Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers,” Breast Cancer Research, vol. 17, article 112, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Papanikolaou, N. Stefanou, S. Dubos et al., “Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes,” Cellular Oncology, vol. 38, no. 2, pp. 155–164, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Basu, K. Combe, F. Kwiatkowski et al., “Cellular expression of cyclooxygenase, aromatase, adipokines, inflammation and cell proliferation markers in breast cancer specimen,” PLoS ONE, vol. 10, no. 10, Article ID e0138443, 2015. View at Publisher · View at Google Scholar
  21. R. Arumugam, A. LeBlanc, D. K. Seilheimer, and D. S. Hardin, “Serum leptin and IGF-I levels in cystic fibrosis,” Endocrine Research, vol. 24, no. 2, pp. 247–257, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. Y.-C. Lee, Y.-J. Chen, C.-C. Wu, S. Lo, M.-F. Hou, and S.-S. F. Yuan, “Resistin expression in breast cancer tissue as a marker of prognosis and hormone therapy stratification,” Gynecologic Oncology, vol. 125, no. 3, pp. 742–750, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Herruzo, J. A. Castilla, A. Ramírez, C. Marcos, and S. Menjón, “Tumour necrosis factor-α and interleukin-1 and -6 in fibrocystic breast disease,” Breast Cancer Research and Treatment, vol. 54, no. 2, pp. 159–164, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Purohit, S. P. Newman, and M. J. Reed, “The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer,” Breast Cancer Research, vol. 4, no. 2, pp. 65–69, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Soncini, I. Caffa, G. Zoppoli et al., “Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity,” The Journal of Biological Chemistry, vol. 289, no. 49, pp. 34189–34204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. A. Assiri, H. F. M. Kamel, and M. F. R. Hassanien, “Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal Saudi females and their possible diagnostic and predictive implications as novel biomarkers,” Disease Markers, vol. 2015, Article ID 253519, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Dalamaga, S. Archondakis, G. Sotiropoulos et al., “Could serum visfatin be a potential biomarker for postmenopausal breast cancer?” Maturitas, vol. 71, no. 3, pp. 301–308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A. M. A. Assiri and H. F. M. Kamel, “Evaluation of diagnostic and predictive value of serum adipokines: leptin, resistin and visfatin in postmenopausal breast cancer,” Obesity Research and Clinical Practice, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Kocełak, M. Olszanecka-Glinianowicz, A. J. Owczarek et al., “Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration in elderly subjects with metabolic syndrome,” Polskie Archiwum Medycyny Wewnetrznej, vol. 125, no. 6, pp. 402–413, 2015. View at Google Scholar · View at Scopus
  30. F. Mannello, F. Maccari, D. Ligi et al., “Breast cyst fluid heparan sulphate is distinctively N-sulphated depending on apocrine or flattened type,” Cell Biochemistry and Function, vol. 33, no. 3, pp. 128–133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Erbas, O. Erten, and M. E. Irfanoglu, “Breast cyst fluid plasmin activity and its effect on TGF-β2 activation,” Cancer Investigation, vol. 26, no. 1, pp. 22–27, 2008. View at Publisher · View at Google Scholar · View at Scopus